All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F18%3AE0107319" target="_blank" >RIV/00843989:_____/18:E0107319 - isvavai.cz</a>

  • Result on the web

    <a href="https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0788-7" target="_blank" >https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-018-0788-7</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/s12933-018-0788-7" target="_blank" >10.1186/s12933-018-0788-7</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

  • Original language description

    Cardiovascular disease (CVD) is the most significant prognostic factor in individuals with type 2 diabetes (T2D). However, a significant number of individuals may develop CVD that does not present with the classic angina-related or heart failure symptoms. In these cases, CVD may seem to be 'silent' or 'asymptomatic', but may be more accurately characterised as unrecognised diabetic cardiac impairment. An initial step to raise awareness of unrecognised CVD in individuals with T2D would be to reach a consensus regarding the terminology used to describe this phenomenon. By standardising the terminologies, and agreeing on the implementation of an efficient screening program, it is anticipated that patients will receive an earlier diagnosis and appropriate and timely treatment. Given the availability of anti-diabetic medications that have been shown to concomitantly reduce CV risk and mortality, it is imperative to improve early identification and initiate treatment as soon as possible in order to enable as many patients with T2D as possible to benefit.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30202 - Endocrinology and metabolism (including diabetes, hormones)

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Cardiovascular diabetology

  • ISSN

    1475-2840

  • e-ISSN

  • Volume of the periodical

    17

  • Issue of the periodical within the volume

    145

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    6

  • Pages from-to

    1-6

  • UT code for WoS article

    000450904500001

  • EID of the result in the Scopus database

    2-s2.0-85056977005